Expanded safety analysis of pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, in patients with acute myeloid leukemia and myelodysplastic syndromes.
R T SwordsJ WattsH P ErbaJ K AltmanM MarisFaiz AnwarZ HuaH SteinH FaesselF SedaratiB J DezubeF J GilesB C MedeirosD J DeAngeloPublished in: Blood cancer journal (2017)